Project Grant R01HL187022
Award Date 8/1/26
Completion Date 7/31/30
Dollars Obligated $3.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Oakland, CA 94612, USA
Similar Awards
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Kaiser Foundation Hospitals $663,216 on July 1, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to conduct a five-year study examining bone and muscle properties associated with fracture risk among persons living with HIV infection. The research leverages the Kaiser Permanente Southern California HIV Registry and electronic health records to compare bone, muscle, and body...
- The National Heart, Lung, and Blood Institute awarded Kaiser Foundation Hospitals $200,832 on August 12, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837, Assistance Listing project grant K01HL186353) to support a five-year research training and development initiative focused on cardiovascular disease prevention in Spanish-speaking families. The award funds Dr. Formagini's research to adapt an existing text-messaging lifestyle change program—originally developed for...
- The National Heart, Lung, and Blood Institute awarded Kaiser Foundation Hospitals $193,055 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support Dr. Vy Ho's transition to an independent surgeon-informaticist specializing in abdominal aortic aneurysm diagnosis, surveillance, and treatment. The award funds formal training in computer vision for cardiovascular risk prediction, risk factors for abdominal aortic aneurysms in underrepresented patient...
- The National Heart, Lung, and Blood Institute awarded Kaiser Foundation Hospitals' Kaiser Foundation Research Institute $1,470,439 on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate optimal physical activity timing and 24-hour activity composition for prevention of hypertensive disorders of pregnancy. The research addresses gaps in understanding how the timing and intensity of physical activity during pregnancy—particularly early versus...
- The National Heart, Lung, and Blood Institute awarded Kaiser Foundation Hospitals $780,960 on July 3, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to evaluate treatment adherence interventions for young adults with obstructive sleep apnea. The award funds a five-year randomized controlled trial testing two interventions designed to improve continuous positive airway pressure (CPAP) treatment adherence among young adults ages 18–25. The research addresses a documented...
- The National Heart, Lung, and Blood Institute awarded Northern California Institute For Research And Education, Inc. (NCIRE) $3.002 million on August 7, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a prospective longitudinal study of cardiac fibro-inflammation progression in women with HIV. The research repeats cardiac magnetic resonance imaging in returning participants approximately eight years after their initial scans, drawing from the MACS-WIHS...
- The National Institute of Mental Health awarded Kaiser Foundation Hospitals $418,224 on March 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a mixed-methods study identifying medication adherence trajectory profiles in older patients living with HIV and multiple chronic conditions. The research applies group-based trajectory modeling to medication refill data spanning a 36-month observation period in patients aged 50–99 years, followed by 75 semi-structured...
- The Food and Drug Administration awarded Kaiser Foundation Hospitals a cooperative agreement totaling $2,996,928 on September 22, 2025, under the Food and Drug Administration Research program (CFDA 93.103). The award funds development of artificial intelligence-enabled echocardiographic biomarkers and real-world electronic health record data models to improve early detection and risk stratification of cancer therapy-related cardiac dysfunction (CTRCD) in cancer survivors. The recipient will...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of California, San Francisco $3,093,164 on June 10, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate an expanded HIV Synthesis microsimulation model incorporating hypertension and cardiovascular disease outcomes, evaluate health effects and cost-effectiveness of implementation strategies for HIV-hypertension care integration across West, East, and Southern Africa...
- The National Heart, Lung, and Blood Institute awarded Beckman Research Institute of The City of Hope $697,806 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop integrative machine learning approaches that decode cardiomyocyte subtype dynamics in heart failure progression. The research addresses molecular mechanisms governing the transition from adaptive cardiac hypertrophy to pathological heart failure. The recipient will generate and analyze...